Skip to content
Screener

Gross margin at other companies

Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
150%-15.6pp
uniQure logo
uniQureQURE
92.5%+4.6pp
AdaptHealth logo
AdaptHealthAHCO
18.3%-1.6pp

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$45.7M-6.6%
Net income-$43.4M-4.8%
EPS (diluted)-$0.39+15.2%

Balance sheet

See full
Cash & equivalents$49.3M-15.1%
Total debt$5.3M-11.9%
Total equity$239.2M+42.5%
Total assets$264.6M+36.0%

Cash flow

See full
Operating cash flow-$31.4M-24.5%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$2.7B+269%
Enterprise value$2.65B+291%

Profitability

See full
Operating margin-47,349.8%-47,409pp
Net margin-45,096.2%-45,152pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-74.7%-9.5pp
Debt / equity0.0×
Current ratio12.1×+3.4×

Where this comes from

Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:04 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336682

FAQ

What is Amylyx Pharmaceuticals, Inc.'s gross margin?
Amylyx Pharmaceuticals, Inc. (AMLX) reported gross margin of 100% in Q2 2025.
How has Amylyx Pharmaceuticals, Inc.'s gross margin changed year-over-year?
Amylyx Pharmaceuticals, Inc.'s gross margin increased by 7.4% year-over-year, from 93.1% to 100%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.

Ask your AI about Amylyx Pharmaceuticals, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude